Back
Genscript Biotech Vs. CASI Pharmaceuticals Industry Stock Comparison
Buy
65
GNNSF
Genscript Biotech
Last Price:
1.25
Seasonality Move:
-4.63%
Sell
21
CASI
CASI Pharmaceuticals
Last Price:
3.17
Seasonality Move:
4.53%
Buy
65
Genscript Biotech (GNNSF)
is a Buy
Is Genscript Biotech a Buy, Sell or Hold?
- The current Genscript Biotech [GNNSF] share price is $1.25. The Score for GNNSF is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- GNNSF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
CASI Pharmaceuticals (CASI)
is a Sell
Is CASI Pharmaceuticals a Buy, Sell or Hold?
- The current CASI Pharmaceuticals [CASI] share price is $3.07. The Score for CASI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GNNSF Stock Price Chart
What is Genscript Biotech's stock price today?
-
The Genscript Biotech share price today is $1.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNNSF is experiencing slight buying pressure.
CASI Stock Price Chart
What is CASI Pharmaceuticals's stock price today?
-
The CASI Pharmaceuticals share price today is $3.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight selling pressure.
GNNSF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 15.99 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.27 - 1.43) | Sell |
Bollinger Bands (100): | (1.34 - 1.56) | Sell |
CASI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 32.64 | Sell |
Chaikin Money Flow: | -6265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.53 - 5.49) | Sell |
Bollinger Bands (100): | (4.83 - 6.87) | Sell |
GNNSF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Sell |
20-day SMA: | 1.32 | Sell |
50-day SMA: | 1.39 | Sell |
200-day SMA: | 1.49 | Sell |
8-day EMA: | 1.27 | Sell |
20-day EMA: | 1.32 | Sell |
50-day EMA: | 1.37 | Sell |
200-day EMA: | 1.57 | Sell |
CASI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.37 | Sell |
20-day SMA: | 4.24 | Sell |
50-day SMA: | 5.15 | Sell |
200-day SMA: | 4.82 | Sell |
8-day EMA: | 3.45 | Sell |
20-day EMA: | 4.07 | Sell |
50-day EMA: | 4.88 | Sell |
200-day EMA: | 5.07 | Sell |
Genscript Biotech Earnings Growth & GNNSF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Genscript Biotech Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CASI Pharmaceuticals Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |